[Inflammatory myofibroblastic tumor--benign or malign?].
Virtanen
Katri
K
Turun yliopisto, kliinis-teoreettinen laitos, patologia, TYKS-laboratoriot, patologia Kiinamyllynkatu 10, 20520 Turku. katri.virtanen@utu.fi
Alanen
Kalle
K
Kallajoki
Markku
M
Mattila
Kimmo
K
Miettinen
Markku
M
D001859:Bone Neoplasms / Q000556:secondary* / Q000628:therapy; D001932:Brain Neoplasms / Q000556:secondary* / Q000628:therapy; D005260:Female; D006801:Humans; D007249:Inflammation / Q000628:therapy; D008175:Lung Neoplasms / Q000473:pathology* / Q000628:therapy; D008297:Male; D008875:Middle Aged; D009379:Neoplasms, Muscle Tissue / Q000556:secondary* / Q000628:therapy; D010296:Parietal Lobe; D011379:Prognosis; D016896:Treatment Outcome